Seagen
SGEN
#546
Rank
S$55.92 B
Marketcap
S$296.42
Share price
-0.07%
Change (1 day)
63.54%
Change (1 year)

Seagen (SGEN) - Total assets

Total assets on the balance sheet as of September 2023 : S$4.70 Billion

According to Seagen 's latest financial reports the company's total assets are S$4.70 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Seagen - Total assets on balance sheet (from 2001 to 2023)

Total assets by year

Year Total assets Change
2022-12-31S$4.92 B-2.04%
2021-12-31S$5.02 B-5%
2020-12-31S$5.29 B77.98%
2019-12-31S$2.97 B44.8%
2018-12-31S$2.05 B74.9%
2017-12-31S$1.17 B-3.23%
2016-12-31S$1.21 B-4.16%
2015-12-31S$1.26 B108.78%
2014-12-31S$0.60 B-1.08%
2013-12-31S$0.61 B6.35%
2012-12-31S$0.57 B4.69%
2011-12-31S$0.55 B29.57%
2010-12-31S$0.42 B-22.04%
2009-12-31S$0.54 B103.08%
2008-12-31S$0.26 B25.6%
2007-12-31S$0.21 B42.67%
2006-12-31S$0.14 B-0.05%
2005-12-31S$0.14 B-22.87%
2004-12-31S$0.19 B39.48%
2003-12-31S$0.13 B52.83%
2002-12-31S$91.15 M-21.87%
2001-12-31S$0.11 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
ImmunoGen
IMGN
S$1.06 B-77.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$37.84 B 703.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
S$0.84 B-82.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
S$0.13 B-97.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$270.49 B 5,643.43%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
S$106.86 B 2,168.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
AbbVie
ABBV
S$173.51 B 3,584.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$125.55 B 2,565.99%๐Ÿ‡บ๐Ÿ‡ธ USA